Clinical Trial Update: Study to Evaluate Cycle Control With Norgestimate/Ethinyl Estradiol and Drospirenone/Ethinyl Estradiol in Healthy Sexually Active Females [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating cycle control of two combined oral contraceptives in healthy sexually active females has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contraception

Drugs mentioned

• Drospirenone-Ethinyl Estradiol (Drospirenone and Ethinyl Estradiol)
• Norgestimate/Ethinyl Estradiol (Norgestimate and Ethinyl Estradiol)

Snippet

Sponsor: Ortho-McNeil Janssen Scientific Affairs, LLC | Conditions: Contraception | Phase 4 | Status: COMPLETED | Results posted: 2010-05-25